Top Ten Common Prejudices About Polyethylene Naphthalate Market.

Image
In 2014, the global polyethylene naphthalate market was worth USD 827.0 million, and it is expected to grow at a CAGR of 7.5 percent over the next five years. Because of its improved thermal and barrier properties, such as oxidation resistance, polyethylene naphthalate (PEN) is primarily used in packaging applications. Over the forecast period, rising demand for high-strength photographic films is likely to drive market expansion. polyethylene naphthalate market Because of their higher stiffness modulus, PEN films are a major component of food packaging applications, providing increased barrier properties and enhancing the material's strength. These films are also used to make pressure sensitive tapes and thermal sheets. They are also involved in the protection of solar cells. Forward integration of raw material providers in PEN manufacturing is a feature of the polyethylene naphthalate market. These businesses actively consume raw materials in order to create their products. Con...

7 Things To Know About Mental Health Software Market.



The global behavioural health software market is predicted to grow at a CAGR of 19.6% from USD 2.0 billion in 2021 to USD 4.9 billion by 2026, up from USD 2.0 billion in 2021. The growth of this market is being fueled by factors such as increasing adoption of behavioural health software, government funding, government initiatives to encourage EHR adoption in behavioural health organisations, favourable behavioural health reforms in the United States, and high demand for mental health services despite a provider shortage.

COVID-19 is a newly identified novel coronavirus that causes an infectious sickness. COVID-19, which was mostly unknown until the outbreak in Wuhan, China, in December 2019, went from a regional issue to a global pandemic in just a few weeks. On March 11, 2020, the World Health Organization (WHO) proclaimed COVID-19 a pandemic. The effects of the coronavirus epidemic and the ensuing statewide lockdowns may be seen in a variety of businesses. The general expansion of many sectors has been severely hampered, particularly in nations where COVID-19 is prevalent, such as India, China, Brazil, the United States, and a number of European countries (including Russi).

While businesses like oil and petroleum, aeronautics, and mining are seeing a drop in revenue, the healthcare, biotechnology, and pharmaceutical industries are taking advantage of the situation to serve as many patients and healthcare professionals as possible. As medical practises of all sizes are under tremendous strain, healthcare professionals must rely on EHR solutions to monitor and treat patients, the COVID-19 epidemic is presenting enormous prospects for the behavioural health software market to grow.

Governments are concerned about high healthcare expenses for the treatment of behavioural health-related issues or mental diseases. Depression is a common mental condition worldwide, affecting more than 264 million individuals of all ages. In 2020, the global cost of treating mental diseases was USD 2.5 trillion; by 2030, this amount is expected to rise to USD 6 trillion (Source: Lancet Commission). Furthermore, significant mental diseases are predicted to cost the United States USD 193.2 billion in missed earnings per year (Source: National Alliance of Mental Illness). Mental health issues cost more than USD 42.4 billion (CAD 51 billion) in Canada each year (source: Centre for Addiction and Mental Health).

The requirement for and development of unnecessary documentation (leading in clinician productivity loss) and inefficient revenue cycle management by behavioural health organisations are the primary causes of high treatment costs. The need to address these difficulties has increased interest in and use of behavioural health software as a means of decreasing prescription errors and paperwork, increasing productivity by ensuring quick access to patient data, improving workflow efficiency, and lowering healthcare costs. These advantages have prompted widespread use of mental health software, particularly among large hospitals and community clinics.

Providers in behavioural health are most concerned about data privacy. Behavioral health providers are not permitted to discuss information about patients with mental illnesses or substance abuse with anybody who is not involved in the patient's treatment. However, by integrating data utilising behavioural IT tools, any healthcare worker who isn't involved in the case can gain access to the patient's information. In the United States, the HIPAA Journal reported 365 healthcare data breaches in 2018, up 68% from the total number of breaches documented in 2012. According to an article in the HIPAA Journal,

The most difficult task for healthcare institutions, especially in emerging economies, is overcoming budgetary restraints. Nonetheless, the amount of data stored has become so significant that IT infrastructure has begun to serve as the backbone of healthcare organisations. Behavioral health software solutions are currently somewhat expensive software solutions. These systems' maintenance and software update costs might occasionally exceed the program's purchase price. Support and maintenance services, which include software upgrades in response to changing user needs, are a recurring expense that can account for nearly 30% of the total cost of ownership.

Comments

Popular posts from this blog

Top Ten Common Prejudices About Polyethylene Naphthalate Market.

The Ultimate Revelation Of Coal Fired Power Generation Market.

5 Various Ways To Do Obesity Management Drugs Market.